A New Way to Assess Cardiovascular Disease Risk

Early detection of cardiovascular disease can be life-changing. Various methods are used to assess risk. Problem is, many identify cardiac disease only after it has progressed to later stages. High-sensitivity troponin screening uses a blood sample to detect elevated risk of cardiovascular disease, years before most other methods. In fact, hs-Troponin is so sensitive that it may allow clinicians to forecast heart attacks a decade before they happen. In this conversation between our Wellness host, Dr. Peter Nord, Medcan’s chief medical officer, and Tricia Ravalico, Director, Global Scientific Leadership and Education at Abbott, we explore the development of the hs-Troponin test and describe why it is so innovative.

Check out the episode webpage for links and more info.